IDH1 and astrocytoma (excluding glioblastoma): It should be noted that glioblastomas, by current WHO classification, are IDH-wildtype tumors; the presence of an IDH mutation instead defines astrocytoma, IDH-mutant, or oligodendroglioma, IDH-mutant and 1p/19q codeleted, entities with distinct biology and prognosis [16].